期刊文献+

原发性甲状腺功能亢进症合并甲状腺微小癌:附32例报告 被引量:4

Analysis of 32 cases with primary hyperthyroidism and concurrent thyroid microcarcinoma
下载PDF
导出
摘要 目的 探讨原发性甲状腺功能亢进症 (甲亢 )合并甲状腺微小癌的诊断和治疗。方法 回顾性分析 1994年 1月~ 2 0 0 2年 12月收治的经外科手术及病理证实为原发性甲亢合并甲状腺微小癌 3 2例的临床资料。结果 全组微小癌发病率为 1.0 7%。术前无 1例确诊。 3 2例均行双侧甲状腺次全切除术。术中见双侧甲状腺弥漫性肿大 ,11例发现有小结节或星状疤痕样改变。均无淋巴结转移 ,均末行二次手术。全组病例术后随访 1~ 10 (平均 5 .5 )年均未见甲亢或甲状腺癌复发。结论 甲亢合并甲状腺微小癌的临床诊断较困难 ,多于手术后病理诊断。手术治疗效果良好 ,预后较好 。 Objective To investigate the diagnosis and treatment. Of primary hyperthyroidism and concurrent thyroid microcarcinoma. Methods A retrospective analysis of 32 cases of primary hyperthyroidism and concurrent thyroid microcacinoma proved by postoperative pathology and were admilted between January 1994 and December 2002.Resulth The morbidity was 1.07%.No case had been diagnosed before operation.All of 32 cases underwent bilateral subtotal thyroidectomy.All cases showed diffase goiter and 11 cases showed small thyroid nodules at operation. There was no evidence of lymph node metastasis. No case had reoperation. No case of recurrent hyperthyroidism nor cancer was found during the 1 to 10 (mean5.5)years follow up. Conclusion The clinical diagnosis of primary hyperthyroidism and concurrent thyroid microcarcinoma is difficult and chiefly depends on postoperative pathology. Surgical treatment gives good results and has a better prognosis ,but long term follow up is still needed.
出处 《中国普通外科杂志》 CAS CSCD 2004年第11期834-836,共3页 China Journal of General Surgery
关键词 甲状腺机能亢进症 甲状腺肿瘤/外科学 HYPERTHYROIDISM THYROID NEOPLASMS/surg
  • 相关文献

参考文献5

二级参考文献4

  • 1张树华,滨州医学院学报,1992年,15卷,289页
  • 2张树华,实用癌症杂志,1990年,5期,158页
  • 3徐少明,中华医学杂志,1985年,65卷,174页
  • 4韦清江,四川医学,1981年,2卷,87页

共引文献34

同被引文献32

  • 1吕新生.提高甲状腺癌患者的治疗效果及生活质量[J].中国普外基础与临床杂志,2004,11(6):481-482. 被引量:7
  • 2武正炎,沈美萍.结节性甲状腺肿诊治进展[J].中国普外基础与临床杂志,2004,11(6):483-485. 被引量:50
  • 3张惠健,张轶斌.甲状腺结节的诊治近况[J].中国临床医学,2005,12(5):958-959. 被引量:13
  • 4潘开云,张文山,方艺聪,郭银枞.甲状腺良性结节合并甲状腺癌32例分析[J].中国肿瘤临床与康复,2005,12(6):567-568. 被引量:3
  • 5Aust G,Eichler W,Laus S,et al.CD97:a dedifferentiation marker in human thyroid carcinoma[J].Cencer Res,1997,57 (5):1798 -1807.
  • 6Suzuki S,Fukushima T,Ami H,et al.New attempt of preoperative differential diagnosis of thyroid neoplasms by telomerase activity measurement[J].Oncol Rep,2002,9 (3):539-546.
  • 7Umbricht CB,Saji M,Westra WH,et al.Telomerase activity:A marker to distinguish follicular thyroid adenoma from carcinoma[J].Cancer Res,1997,57 (11):2144 -2152.
  • 8McGriff NJ,Csako G,Gourgiotis L,et al.Effects of thyroid hormone suppression therapy onadverse clinical outcomes in thyroid cancer[J].Ann Med,2002,34(7 -8):554 -560.
  • 9Settakorn J,Chaiwun B,Thamprasert K,e t al.Fine needle aspiration of the thyroid gland[J].J Med Assoc Thai,2001,84 (10):1401 -1411.
  • 10Gibelin H,Essque D,Jones C,et al.Increased calcitonin level in thyroid nodules without medullary carcinoma[J].Br J Surg,2005,92(5):574-578.

引证文献4

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部